GEM 132 antisense oligonucleotide data

HYBN presented Phase I results of GEM 132

Read the full 84 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE